Jubilant Pharmova Ltd. Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹907.6Market Cap
₹ 14,449 Cr.Stock P/E
37.2ROE
6.53 %RSI
57.2Trend
BearishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary novel drugs.[1]
Jubilant Pharmova Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Jubilant Pharmova Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Jubilant Pharmova Ltd share price chart currently indicates a Bearish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 907.6 |
| RSI (14) | 57.2 |
| 50 DMA | 944.32 |
| 200 DMA | 964.54 |
| Trend | Bearish |
| A/D Rating | B |
| RS Rating | 17 |
| EPS Rating | 14 |
| TI65 | 0.94 |
| TI65 Trend | Bearish |
Pivot Points Analysis
Daily pivot points for Jubilant Pharmova Ltd. calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹964.85 |
| R2 | ₹939.8 |
| R1 | ₹923.7 |
| PP | ₹898.65 |
| S1 | ₹882.55 |
| S2 | ₹857.5 |
| S3 | ₹841.4 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 14,449 Cr. |
| Current Price | ₹ 908 |
| High / Low | ₹ 1,185 / 784 |
| Stock P/E | 37.2 |
| Book Value | ₹ 445 |
| Dividend Yield | 0.55 % |
| ROCE | 8.99 % |
| ROE | 6.53 % |
| Face Value | ₹ 1.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Jun 2023 | 1,587 | 6 | 11% |
| Sep 2023 | 1,680 | 62 | 14% |
| Dec 2023 | 1,677 | 66 | 13% |
| Mar 2024 | 1,759 | -62 | 15% |
| Jun 2024 | 1,732 | 482 | 15% |
| Sep 2024 | 1,752 | 102 | 17% |
| Dec 2024 | 1,822 | 101 | 16% |
| Mar 2025 | 1,929 | 151 | 18% |
| Jun 2025 | 1,901 | 102 | 15% |
| Sep 2025 | 1,966 | 120 | 17% |
| Dec 2025 | 2,122 | 56 | 14% |
| Mar 2026 | 2,290 | 119 | 15% |
| Jun 2026 | 2,229 | 56 | 11% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 54.02% |
| FIIs | 20.70% |
| DIIs | 3.72% |
| Public | 19.32% |
| Others | 2.23% |
| No. of Shareholders | 36,546 |
| Government | 0.00% |
Pros and Cons
Pros
Cons
- Primary trend direction remains weak, stuck underneath major defensive supply barriers.
Related NSE Stocks
SBFC Finance Ltd.
View Share Price Analysis →Urban Company Ltd.
View Share Price Analysis →Welspun Corp Ltd.
View Share Price Analysis →Adani Enterprises Ltd.
View Share Price Analysis →Exide Industries Ltd.
View Share Price Analysis →Motilal Oswal Financial Services Ltd.
View Share Price Analysis →Yes Bank Ltd.
View Share Price Analysis →JSW Energy Ltd.
View Share Price Analysis →Endurance Technologies Ltd.
View Share Price Analysis →Oil India Ltd.
View Share Price Analysis →JSW Steel Ltd.
View Share Price Analysis →Capri Global Capital Ltd.
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Jubilant Pharmova Ltd share?
Based on the latest closing data, the technical momentum for Jubilant Pharmova Ltd is currently evaluated as Bearish. The stock is exhibiting an RSI (14) of 57.2, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (944.32) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Jubilant Pharmova Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Jubilant Pharmova Ltd today centers at a Pivot Point (PP) of ₹898.65. Upside resistance challenges are calculated at R1: ₹923.7, R2: ₹939.8, and R3: ₹964.85. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹882.55, S2: ₹857.5, and S3: ₹841.4.
How does the fundamental ROE and P/E ratio look for Jubilant Pharmova Ltd?
Jubilant Pharmova Ltd is currently trading with a valuation metrics context of a Stock P/E of 37.2, against a core structural efficiency Return on Equity (ROE) standing at 6.53 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 14, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Jubilant Pharmova Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Structural Downward Distribution Phase (Avoid / Sell Setup). Jubilant Pharmova L... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of B, a Relative Strength (RS) ranking of 17, and long-term trend backing from the TI65 indicator (Bearish pattern).